Your browser doesn't support javascript.
loading
Safety and effectiveness of certolizumab pegol in Japanese patients with rheumatoid arthritis: Results from a 24-week post-marketing surveillance study.
Kameda, Hideto; Nishida, Keiichiro; Nanki, Toshihiro; Watanabe, Akira; Oshima, Yukiya; Momohara, Shigeki.
Affiliation
  • Kameda H; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Toho University (Ohashi Medical Center), Tokyo, Japan.
  • Nishida K; Department of Orthopaedic Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Nanki T; Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Toho University (Omori Medical Center), Tokyo, Japan.
  • Watanabe A; Research Division for Development of Anti-Infective Agents, Faculty of Medical Science and Welfare, Tohoku Bunka Gakuen University, Sendai, Japan.
  • Oshima Y; PMS Group, Drug Safety, UCB Pharma, Tokyo, Japan.
  • Momohara S; Department of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, Japan.
Mod Rheumatol ; 33(3): 460-471, 2023 Apr 13.
Article in En | MEDLINE | ID: mdl-35822806
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Antirheumatic Agents Type of study: Prognostic_studies / Screening_studies Limits: Humans Language: En Journal: Mod Rheumatol Year: 2023 Document type: Article Affiliation country: Japan Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Antirheumatic Agents Type of study: Prognostic_studies / Screening_studies Limits: Humans Language: En Journal: Mod Rheumatol Year: 2023 Document type: Article Affiliation country: Japan Country of publication: United kingdom